GlobeNewswireCocaine Use Disorder Pipeline Evolves as Novel Therapeutic Assets Enter the Market
While there are no FDA-approved medications for the treatment of cocaine use disorder, NIDA supports a robust medication development pipeline in this area. DelveInsight’s analysis depicts a robust Cocaine Use Disorder Pipeline with 12+ active players in the domain working on 12+ pipeline therapies.Los Angeles, USA, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Cocaine Use Disorder Pipeline Evolves as Novel Therapeutic Assets Enter the Market While there are no FDA-approved medications for the treatment of
InStyleRoyals' Go-To Rain Boots Are Quietly Marked Down Just in Time for Fall
Meghan Markle, Princess Diana, and even the Queen of England all wore them.
GlobeNewswireHUTCHMED Announces Closing of Divestment of Non-Core OTC Joint Venture
HONG KONG and FLORHAM PARK, N.J., Sept. 29, 2021 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) today announces that, further to its announcement in March 2021 and following receipt of regulatory approval, it has completed the sale of its entire indirect interest in Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited (“HBYS”), a non-core and non-consolidated over-the-counter (“OTC”) drug joint venture business, to GL Mountrose Investment